File: b-be-07-bvw3-fiche-dinformation-destinee-au-public.pdfTrial reference: A multi-centre phase I study to evaluate the safety and tolerability of a heterologous prime-boost vaccination with INX102-3697 HBV pDNA/INX102-0557 HBV MVA in healthy volunteers and HBeAg+ chronic hepatitis patientsDoc type: Information for the public
